MANE · Veradermics Incorporated Common Stock
View on chartInsiders & Stakes
| Patrick G. Enright Director | ▲ Buy | Open Market | 2,053,474 Shares held | 2/5/2026 | View profile |
| Longitude Capital Partners V, LLC 10% Owner | ▲ Buy | Open Market | 2,053,474 Shares held | 2/5/2026 | View profile |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▼ Sell | Other | 612,033 Shares held | 8/20/2026 | View profile |
| Vlad Coric Director | ▲ Buy | Open Market | 319,398 Shares held | 2/5/2026 | View profile |
| John W. Childs Director | ▼ Sell | Open Market | 194,117 Shares held | 8/12/2026 | View profile |
| Reid Alexander Waldman Chief Executive Officer | ▼ Sell | Open Market | 170,824 Shares held | 8/17/2026 | View profile |
| Timothy August Durso Chief Technical Officer | ▼ Sell | Open Market | 78,142 Shares held | 8/17/2026 | View profile |
| Hollander David Chief R&D Officer | ▲ Buy | Grant | 9,650 Shares held | 9/1/2026 | View profile |
| Jane M. Grant-Kels Director | ▼ Sell | Other | 2,455 Shares held | 2/5/2026 | View profile |
Transaction History
| Hollander David | ▲ Buy | Grant | 9,650 | $0 | 9/1/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▼ Sell | Other | 151,000 | — | 8/20/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▼ Sell | Other | 149,000 | — | 8/20/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▼ Sell | Open Market | 59,399 | $6.4M | 8/19/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▼ Sell | Open Market | 690,601 | $74.1M | 8/19/2026 |
| Timothy August Durso | ▲ Buy | Option Exercise | 3,452 | $42K | 8/17/2026 |
| Timothy August Durso | ▼ Sell | Open Market | 16,767 | $1.8M | 8/17/2026 |
| Timothy August Durso | ▼ Sell | Open Market | 161 | $18K | 8/17/2026 |
| Reid Alexander Waldman | ▲ Buy | Option Exercise | 3,452 | $42K | 8/17/2026 |
| Reid Alexander Waldman | ▼ Sell | Open Market | 25,234 | $2.7M | 8/17/2026 |
| Reid Alexander Waldman | ▼ Sell | Open Market | 11,527 | $1.2M | 8/17/2026 |
| Timothy August Durso | ▼ Sell | Open Market | 16,306 | $1.8M | 8/17/2026 |
| Reid Alexander Waldman | ▼ Sell | Open Market | 27,490 | $3.0M | 8/17/2026 |
| Reid Alexander Waldman | ▼ Sell | Open Market | 3,000 | $328K | 8/17/2026 |
| Reid Alexander Waldman | ▼ Sell | Open Market | 249 | $28K | 8/17/2026 |
| Timothy August Durso | ▼ Sell | Open Market | 2,348 | $257K | 8/17/2026 |
| Timothy August Durso | ▼ Sell | Open Market | 7,918 | $845K | 8/17/2026 |
| John W. Childs | ▼ Sell | Open Market | 5,000 | $541K | 8/12/2026 |
| John W. Childs | ▼ Sell | Open Market | 15,000 | $1.6M | 8/12/2026 |
| John W. Childs | ▼ Sell | Open Market | 80,000 | $8.6M | 8/12/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 11,183 | $402K | 2/6/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 19,338 | $707K | 2/6/2026 |
| Longitude Capital Partners V, LLC | ▼ Sell | Other | 1,171,121 | — | 2/5/2026 |
| Jane M. Grant-Kels | ▼ Sell | Other | 2,455 | — | 2/5/2026 |
| Vlad Coric | ▼ Sell | Other | 33,706 | — | 2/5/2026 |
| Vlad Coric | ▼ Sell | Other | 33,706 | — | 2/5/2026 |
| Vlad Coric | ▼ Sell | Other | 148,794 | — | 2/5/2026 |
| Vlad Coric | ▼ Sell | Other | 148,794 | — | 2/5/2026 |
| Vlad Coric | ▼ Sell | Other | 78,075 | — | 2/5/2026 |
| Vlad Coric | ▼ Sell | Other | 78,075 | — | 2/5/2026 |
| John W. Childs | ▼ Sell | Other | 520,758 | — | 2/5/2026 |
| John W. Childs | ▲ Buy | Open Market | 294,117 | $5.0M | 2/5/2026 |
| Longitude Capital Partners V, LLC | ▼ Sell | Other | 1,236,631 | — | 2/5/2026 |
| Longitude Capital Partners V, LLC | ▼ Sell | Other | 1,171,121 | — | 2/5/2026 |
| Longitude Capital Partners V, LLC | ▲ Buy | Open Market | 192,647 | $3.3M | 2/5/2026 |
| Longitude Capital Partners V, LLC | ▲ Buy | Open Market | 882,353 | $15.0M | 2/5/2026 |
| Patrick G. Enright | ▼ Sell | Other | 1,171,121 | — | 2/5/2026 |
| Patrick G. Enright | ▼ Sell | Other | 1,171,121 | — | 2/5/2026 |
| Patrick G. Enright | ▲ Buy | Open Market | 192,647 | $3.3M | 2/5/2026 |
| Patrick G. Enright | ▲ Buy | Open Market | 882,353 | $15.0M | 2/5/2026 |
| Timothy August Durso | ▼ Sell | Other | 1,473 | — | 2/5/2026 |
| Reid Alexander Waldman | ▼ Sell | Other | 1,437 | — | 2/5/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 3,832 | $138K | 2/5/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 19,199 | $709K | 2/5/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 38,771 | $1.5M | 2/5/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 17,835 | $690K | 2/5/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 16,563 | $659K | 2/5/2026 |
| Vlad Coric | ▼ Sell | Other | 117,112 | — | 2/5/2026 |
| Vlad Coric | ▲ Buy | Open Market | 58,823 | $1000K | 2/5/2026 |
| Vlad Coric | ▲ Buy | Open Market | 58,823 | $1000K | 2/5/2026 |
| John W. Childs | ▼ Sell | Other | 480,269 | — | 2/5/2026 |
| John W. Childs | ▼ Sell | Other | 906,862 | — | 2/5/2026 |
| Patrick G. Enright | ▼ Sell | Other | 1,236,631 | — | 2/5/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 18,489 | $719K | 2/4/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 53,344 | $2.0M | 2/4/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 25,908 | $987K | 2/4/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 1,720 | $59K | 2/4/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 1,835 | $64K | 2/4/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 2,519 | $91K | 2/4/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 9,168 | $340K | 2/4/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 4,453 | $170K | 2/4/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 3,178 | $124K | 2/4/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 10,004 | $343K | 2/4/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 10,676 | $371K | 2/4/2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | ▲ Buy | Open Market | 14,659 | $532K | 2/4/2026 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Veradermics Momentum Builds, But H2 2026 Readouts Caution
Veradermics has seen growing momentum, but analysts caution that upcoming H2 2026 readouts could influence the stock. The company was included among 12 healthcare stocks that moved higher in Thursday’s intraday session. While the news highlights positive sentiment, investors should note the caution about future readouts. The stock remains near its 52‑week low, with a support level at $97.79.
Veradermics Momentum Builds, But H2 2026 Readouts Caution. Veradermics has seen growing momentum, but analysts caution that upcoming H2 2026 readouts could influence the stock. The company was included among 12 healthcare stocks that moved higher in Thursday’s intraday session. While the news highlights positive sentiment, investors should note the caution about future readouts. The stock remains near its 52‑week low, with a support level at $97.79.